The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 11, 2011, Pages 1649-1660

  Nassar, Khaled ^a,b   Lüke, Julia ^a   Lüke, Matthias ^a   Kamal, Mahmoud ^b   Abd El Nabi, Effat ^c   Soliman, Mahmoud ^c   Rohrbach, Martin ^d   Grisanti, Salvatore ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Fayoum University   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Decorin; Proliferative vitreoretinopathy (PVR); Rabbits; Tractional retinal detachment (TRD); Trauma; Vitrectomy

Indexed keywords

D 8428; DECORIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; NONHUMAN; OCULAR FIBROSIS; PHACOVITRECTOMY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA INJURY; SCORING SYSTEM; TREATMENT OUTCOME; VITRECTOMY; VITREORETINOPATHY;

ANIMALS; DECORIN; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; INTRAVITREAL INJECTIONS; PHACOEMULSIFICATION; RABBITS; RETINA; RETINAL DETACHMENT; TRANSFORMING GROWTH FACTOR BETA; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 80755128427     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1730-9     Document Type: Article

References (67)

1. H Tanihara M Inatani T Koga T Yano A Kimura 2002 Proteoglycans in the eye Cornea 21 S62 S69 12484701 10.1097/01.ico.0000263121.45898.d2
2. M Hagedorn P Esser P Wiedemann K Heimann 1993 Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy Ger J Ophthalmol 2 28 31 7679595 1:CAS:528: DyaK3sXitFSltb0%3D
3. R Iozzo 1999 The biology of the small leucine-rich proteoglycan J Biol Chem 27 18843 18846 10.1074/jbc.274.27.18843 (Pubitemid 29314072)
4. KG Vogel M Paulsson D Heinegard 1984 Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon Biochem J 223 587 597 6439184 1:CAS:528:DyaL2MXitFWg (Pubitemid 15209051)
5. R Fleischmajer LW Fisher ED MacDonald L Jacobs Jr JS Perlish JD Termine 1991 Decorin interacts with fibrillar collagen of embryonic and adult human skin J Struct Biol 106 82 90 2059554 10.1016/1047-8477(91)90065-5 1:STN:280:DyaK3M3otlentg%3D%3D
6. DJ Bidanset C Guidry LC Rosenberg HU Choi R Timpl M Hook 1992 Binding of the proteoglycan decorin to collagen type VI J Biol Chem 267 5250 5256 1544908 1:CAS:528:DyaK38Xhs1ymurc%3D
7. M Winnemoller P Schon P Vischer H Kresse 1992 Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment Eur J Cell Biol 59 47 55 1468447 1:STN:280:DyaK3s7gsF2rsA%3D%3D
8. K Lewandowska HU Choi LC Rosenberg L Zardi LA Culp 1987 Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain J Cell Biol 105 1443 1454 2958485 10.1083/jcb.105.3.1443 1:CAS:528:DyaL2sXlvFGltbk%3D (Pubitemid 18029869)
9. G Schmidt H Robenek B Harrach J Glössl V Nolte H Hörmann H Richter H Kresse 1987 Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin J Cell Biol 104 1683 1691 3584245 10.1083/jcb.104.6.1683 1:CAS:528:DyaL2sXktlOjt7c%3D (Pubitemid 17104538)
10. KG Vogel JA Trotter 1987 The effect of proteoglycans on the morphology of collagen fibrils formed in vitro Coll Relat Res 7 105 114 3621881 1:CAS:528:DyaL2sXlsV2mtbs%3D
11. Y Yamaguchi DM Mann E Ruoslahti 1990 Negative regulation of transforming growth factor- by the proteoglycan decorin Nature 346 281 284 2374594 10.1038/346281a0 1:CAS:528:DyaK3cXkvFWqu7Y%3D (Pubitemid 20227409)
12. Y Takeuchi Y Kodama T Matsumoto 1994 Bone matrix decorin binds transforming growth factor- and enhances its bioactivity J Biol Chem 269 32634 32638 7798269 1:CAS:528:DyaK2cXmvFelsLo%3D
13. Vial C, Gutierrez J, Santander C, Cabrera D, Brandan E (2011) Decorin interacts with CTGF/CCN2 through LRR12 inhibiting its biological activity. J Biol Chem 2011 Mar 23. [Epub ahead of print]
14. N Nili AN Cheema FJ Giordano AW Barolet S Babaei R Hickey MR Eskandarian M Smeets J Butany G Pasterkamp BH Strauss 2003 Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function Am J Pathol 163 869 878 12937128 10.1016/S0002-9440(10)63447-5 1:CAS:528:DC%2BD3sXnsVCjurs%3D
15. DK Moscatello M Santra DM Mann DJ McQuillan AJ Wong RV Iozzo 1998 Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor J Clin Invest 101 406 412 9435313 10.1172/JCI846 1:CAS:528:DyaK1cXmtF2iuw%3D%3D (Pubitemid 28067338)
16. RV Iozzo DK Moscatello DJ McQuillan I Eichstetter 1999 Decorin is a biological ligand for the epidermal growth factor receptor J Biol Chem 274 4489 4493 9988678 10.1074/jbc.274.8.4489 1:CAS:528:DyaK1MXhsFSmtL4%3D (Pubitemid 29113338)
17. 2+ in A431 carcinoma cells J Biol Chem 273 3121 3124 9452417 10.1074/jbc.273.6.3121 1:CAS:528:DyaK1cXhtVyntbk%3D (Pubitemid 28109714)
18. H Hausser P Wedekind T Sperber R Peters A Hasilik H Kresse 1996 Isolation and cellular localization of the decorin endocytosis receptor Eur J Cell Biol 71 325 331 8980902 1:CAS:528:DyaK28XnsFelsLs%3D (Pubitemid 26420041)
19. WF Rachal TC Burton 1979 Changing concepts of failure after retinal detachment surgery Arch Ophthalmol 97 480 483 420635 1:STN:280: DyaE1M7itlCguw%3D%3D (Pubitemid 9098740)
20. DJ Kauffmann JC van Meurs DA Mertens E Peperkamp C Master ME Gerritsen 1994 Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy Invest Ophthalmol Vis Sic 35 900 906 1:STN:280: DyaK2c7ntFGhsw%3D%3D (Pubitemid 24079820)
21. GA Limb BC Little A Meager JA Ogilvie RA Wolstencroft WA Franks AH Chignell DC Dumonde 1991 Cytokines in proliferative vitreoretinopathy Eye 5 686 693 1800167 10.1038/eye.1991.126
22. RP Casaroli-Marano R Pagan S Vilaró 1999 Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells Invest Ophthalmol Vis Sci 40 2062 2072 10440262 1:STN:280:DyaK1Mzms1yktg%3D%3D (Pubitemid 29365171)
23. R Kalluri EG Neilson 2003 Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 1776 1784 14679171 1:CAS:528:DC%2BD3sXhtVSmtLrL (Pubitemid 38063698)
24. P Bornstein 2001 Thrombospondins as matricellular modulators of cell function J Clin Invest 107 929 934 11306593 10.1172/JCI12749 1:CAS:528:DC%2BD3MXivVKjt70%3D (Pubitemid 32323400)
25. M Shah DM Foreman MW Ferguson 1995 Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring J Cell Sic 108 985 1002 1:CAS:528:DyaK2MXkvFaltr4%3D
26. MF Cordeiro JA Gay PT Khaw 1999 Human anti-transforming growth factor-2 antibody: a new glaucoma anti-scarring agent Invest Ophthalmol Vis Sci 40 2225 2234 10476787 1:STN:280:DyaK1MvgsVCgtQ%3D%3D (Pubitemid 29418376)
27. D Siriwardena PT Khaw AJ King 2002 Human antitransforming growth factor beta (2) monoclonal antibody, a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study Ophthalmology 190 427 431 10.1016/S0161-6420(01)00997-6 (Pubitemid 34184907)
28. S Grisanti P Szurman M Warga R Kaczmarek F Ziemssen O Tatar KU Bartz-Schmidt 2005 Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study Invest Ophthalmol Vis Sci 46 191 196 15623773 10.1167/iovs.04-0902 (Pubitemid 40041197)
29. PE Cleary SJ Ryan 1979 Experimental posterior penetrating eye injury in the rabbit I. Method of production and natural history Br J Ophthalmol 63 306 311 465404 10.1136/bjo.63.5.306 1:STN:280:DyaE1M3jt1enuw%3D%3D (Pubitemid 9141408)
30. HT Hsu SJ Ryan 1986 Natural history of penetrating ocular injury with retinal laceration in the monkey Graefes Arch Clin Exp Ophthalmol 224 1 6 3943726 10.1007/BF02144122 1:STN:280:DyaL287gvFGjtw%3D%3D (Pubitemid 16206809)
31. RN Agrawal S He C Spee JZ Cui SJ Ryan DR Hinton 2007 In vivo models of proliferative vitreoretinopathy Nat Protoc 2 67 77 17401340 10.1038/nprot.2007.4 1:CAS:528:DC%2BD2sXhtFGntbzP (Pubitemid 47040070)
32. O Vergara T Ogden SJ Ryan 1989 Posterior penetrating injury to the rabbit eye: effect of blood and ferrous ions Exp Eye Res 49 1115 1126 2612587 10.1016/S0014-4835(89)80030-2 1:CAS:528:DyaK3cXhtlKrsLs%3D (Pubitemid 20043718)
33. JA Cardillo JT Stout L LaBree SP Azen L Omphroy JZ Cui H Kimura DR Hinton SJ Ryan 1997 Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome Ophthalmology 104 1166 1173 9224471 1:STN:280:DyaK2szmslOlug%3D%3D (Pubitemid 27423861)
34. Sehu W, Lee W (2005) Ophthalmic pathology: an illustrated guide for clinicians. Blackwell Publishing Ltd, Massachusetts
35. JA Cardillo ME Farah J Mitre PH Morales RA Costa LA Melo B Kuppermann R Jorge P Ashton 2004 An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy Br J Ophthalmol 88 1201 1205 15317716 10.1136/bjo.2003.039917 1:STN:280:DC%2BD2cvhtlSqtQ%3D%3D (Pubitemid 39141384)
36. Roduit N (2010) JMicroVision: Image analysis toolbox for measuring and quantifying components of high-definition images. Version 1.2.2. http://www.jmicrovision.com. Access on 8 January 2010
37. DG Charteris 1995 Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment Br J Ophthalmol 79 953 960 7488586 10.1136/bjo.79.10.953 1:STN:280:DyaK28%2Fps1Wjuw%3D%3D
38. SJ Ryan 1985 The pathophysiology of proliferative vitreoretinopathy in its management Am J Ophthalmol 100 188 193 4014372 1:STN:280: DyaL2M3kvVOhsA%3D%3D (Pubitemid 15003432)
39. M Kolb PJ Margetts PJ Sime J Gauldie 2001 Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung Am J Physiol Lung Cell Mol Physiol 280 L1327 L1334 11350814 1:CAS:528:DC%2BD3MXksFKmu7c%3D
40. M Ständer U Naumann W Wick M Weller 1999 Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth Cell Tissue Res 296 221 227 10382266 10.1007/s004410051283 (Pubitemid 29219174)
41. B Merle L Malaval J Lawler P Delmas P Clezadin 1997 Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1 J Cell Biochem 67 75 83 9328841 10.1002/(SICI)1097-4644(19971001)67:1<75::AID-JCB8>3.0.CO;2- T 1:CAS:528:DyaK2sXmvFCntbw%3D (Pubitemid 27430325)
42. B Merle L Durussel PD Delmas P Clezardin 1999 Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain J Cell Biochem 75 538 546 10536375 10.1002/(SICI)1097-4644(19991201)75:3<538::AID- JCB17>3.0.CO;2-Y 1:CAS:528:DyaK1MXntFCmtbk%3D (Pubitemid 29521660)
43. Y Yamaguchi E Ruoslahti 1988 Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation Nature 336 244 246 3194009 10.1038/336244a0 1:CAS:528:DyaL1MXitFKiug%3D%3D
44. A De Luca M Santra A Baldi A Giordano RV Iozzo 1996 Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases J Biol Chem 271 18961 18965 8702560 10.1074/jbc.271.31.18961 (Pubitemid 26322772)
45. Y Isaka D Brees K Ikegaya Y Kaneda E Imai N Noble 1996 Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney Nat Med 2 418 423 8597951 10.1038/nm0496-418 1:CAS:528:DyaK28XitVKmtr8%3D (Pubitemid 26191913)
46. S Giri D Hyde R Braun W Gaarde 1997 Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis Biochem Pharmacol 54 1205 1217 9416971 10.1016/S0006-2952(97)00343-2 1:CAS:528:DyaK2sXnsFamu7Y%3D (Pubitemid 27497247)
47. A Logan A Baird M Berry 1999 Decorin attenuates gliotic scar formation in the rat cerebral hemisphere Exp Neurol 159 504 510 10506521 10.1006/exnr.1999.7180 1:CAS:528:DyaK1MXmt1Cmu7w%3D (Pubitemid 29485236)
48. K Fukushima N Badlani A Usas F Riano F Fu J Huard 2001 The use of an antifibrosis agent to improve muscle recovery after laceration Am J Sports Med 29 394 402 11476375 1:STN:280:DC%2BD38%2FisFKrsA%3D%3D (Pubitemid 32661352)
49. RR Mohan R Gupta MK Mehan JW Cowden S Sinha 2010 Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts Exp Eye Re 91 238 245 10.1016/j.exer.2010.05.013 1:CAS:528:DC%2BC3cXovFymsrk%3D
50. PE Cleary G Larus SJ Ryan 1979 Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixture Br J Ophthalmol 64 801 808 10.1136/bjo.64.11.801
51. PE Cleary SJ Ryan 1981 Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey Arch Ophthalmol 99 287 292 7469867 1:STN:280:DyaL3M7jtlShuw%3D%3D (Pubitemid 11184144)
52. PE Cleary SJ Ryan 1979 Experimental posterior penetrating eye injury in the rabbit II. Histology of wound, vitreous, and retina Br J Ophthalmol 63 312 321 465405 10.1136/bjo.63.5.312 1:STN:280:DyaE1M3jt1emsg%3D%3D (Pubitemid 9141409)
53. HT Hsu SJ Ryan 1986 Experimental retinal detachment in the rabbit. Penetrating ocular injury with retinal laceration Retina 6 66 69 3704354 10.1097/00006982-198600610-00007 1:STN:280:DyaL283gslejuw%3D%3D
54. CE Margo A Lee 1995 Fixation of whole eyes: the role of fixative osmolarity in the production of tissue artifact Graefe's Arch Clin Exp Ophthalmol 233 366 370 10.1007/BF00200486 1:STN:280:DyaK2Mvgt1Omsw%3D%3D
55. MS Blumenkranz A Ophir AJ Clafiin A Kajek 1982 Fluorouracil for the treatment of massive preretinal proliferation Am J Ophthalmol 94 458 467 6182799 1:CAS:528:DyaL38XmtVygtro%3D (Pubitemid 12032504)
56. DM Fastenberg KR Diddie N Sorgente SJ Ryan 1982 A comparison of different cellular innocula in an experimental model of massive periretinal proliferation Am J Ophthalmol 93 559 564 7081354 1:STN:280:DyaL383gtlKgsA%3D%3D (Pubitemid 12107404)
57. DM Fastenberg KR Diddie K Dorey SJ Ryan 1982 The role of cellular proliferation in an experimental model of massive periretinal proliferation Am J Ophthalmol 93 565 572 7081355 1:STN:280:DyaL383gtlKgsQ%3D%3D (Pubitemid 12107405)
58. T Hida DB Chandler SM Sheta 1987 Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye Graefes Arch Clin Exp Ophthalmol 225 303 307 3653728 10.1007/BF02150154 1:STN:280:DyaL1c%2FgsFynug%3D%3D (Pubitemid 17092227)
59. Au Eong KG, Kent D, Pieramici DJ (2002) Section III Mechanical globe injuries, chapter 23 vitreous and retina. In: Kuhn F, Pieramici DJ (eds) Ocular trauma principles and practice. Thieme Medical Publishers, New York, p 224
60. RA Mittra WF Mieler 1999 Controversies in the management of open-globe injuries involving the posterior segment Surv Ophthalmol 44 215 225 10588440 10.1016/S0039-6257(99)00104-6 1:STN:280:DC%2BD3c%2FltlKlsw%3D%3D (Pubitemid 29535466)
61. SC Spalding P Sternberg Jr 1990 Controversies in the management of posterior segment ocular trauma Retina 10 Suppl 1 S76 S82 2191387
62. NK Wang YP Chen L Yeung KJ Chen AN Chao YH Kuo JS Lee CC Lai 2007 Traumatic pediatric retinal detachment following open globe injury Ophthalmologica 221 255 263 17579292 10.1159/000101928 (Pubitemid 46956804)
63. Ashton P (2006) Retinal Drug Delivery. In: Jaffe JG, Ashton P, Pearson PA (eds) Intraocular drug delivery. Taylor and Francis Group, New York, pp 11-12
64. P Girard G Mimoun I Karpouzas G Montefiore 1994 Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery Retina 14 417 424 7899716 10.1097/00006982-199414050-00005 1:STN:280:DyaK2M3gslKiug%3D%3D
65. H Nagasaki K Shinagawa 1995 Risk factors for proliferative vitreoretinopathy Curr Opin Ophthalmol 6 70 75 10150873 10.1097/00055735- 199512000-00012 1:STN:280:DyaK2MzpvF2nsg%3D%3D
66. RR Mohan JC Tovey R Gupta A Sharma A Tandon 2011 Decorin biology, expression, function and therapy in the cornea Curr Mol Med 11 110 128 21342131 1:CAS:528:DC%2BC3MXktFOmu78%3D
67. J Meenakshi S Vidyameenakshi D Ananthram KM Ramakrishnan V Jayaraman M Babu 2009 Low decorin expression along with inherent activation of ERK1, 2 in ear lobe keloids Burns 5 519 526 10.1016/j.burns.2008.07.012